Literature DB >> 15307134

Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas.

Andelko Hrzenjak1, Michaela Tippl, Marie-Luise Kremser, Bettina Strohmeier, Christian Guelly, Doris Neumeister, Sigurd Lax, Farid Moinfar, Ali Dastranj Tabrizi, Narges Isadi-Moud, Kurt Zatloukal, Helmut Denk.   

Abstract

Endometrial stromal sarcomas are rare uterine tumours. Whereas the histology and immunohistochemistry of these tumours are well documented, almost nothing is known about the molecular mechanisms involved in their pathogenesis. To characterize the genes altered in these malignancies, a genome-wide cDNA library was generated by suppression subtractive hybridization and a set of differentially expressed clones was isolated. These were then used to produce custom-spotted cDNA arrays. Genes deregulated in endometrial stromal sarcomas were identified by cDNA array hybridization and were confirmed by quantitative real-time PCR analyses and in situ hybridization. Following cDNA array analysis, more than 300 genes deregulated in endometrial stromal sarcoma were selected and sequenced. Among the most significantly deregulated genes were those of secreted frizzled-related proteins (SFRPs), in particular secreted frizzled-related protein 4 (SFRP4). SFRPs are putative modulators of the Wnt-signalling pathway and play a role in different cellular events including cell proliferation. Compared with normal endometrium, the expression of SFRP4 was decreased in both low-grade endometrial stromal sarcoma (ESS; n = 10) and undifferentiated endometrial sarcoma (UES; n = 4), being lower in the latter more aggressive form. These results were verified on paraffin wax-embedded tissue by quantitative real-time PCR analysis and in situ hybridization. Furthermore, the expression of beta-catenin, an important component of the Wnt-signalling pathway, was regulated in an opposite manner to SFRP4, being particularly increased in undifferentiated sarcomas. The activation of the Wnt-signalling pathway was additionally supported by the immunohistochemical demonstration that beta-catenin was translocated to the nucleus in UES. SFRP4 may therefore be a putative tumour suppressor involved in deregulation of the Wnt pathway and in the pathogenesis of ESS and UES. Copyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307134     DOI: 10.1002/path.1616

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  18 in total

1.  Global gene expression profiling of proliferative phase endometrium reveals distinct functional subdivisions.

Authors:  Rafaella G Petracco; Alice Kong; Olga Grechukhina; Graciela Krikun; Hugh S Taylor
Journal:  Reprod Sci       Date:  2012-05-22       Impact factor: 3.060

Review 2.  JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue.

Authors:  Andelko Hrzenjak; Farid Moinfar; Fattaneh A Tavassoli; Bettina Strohmeier; Marie-Luise Kremser; Kurt Zatloukal; Helmut Denk
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

3.  Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Authors:  Ramez N Eskander; Shamshad Ali; Thanh Dellinger; Heather A Lankes; Leslie M Randall; Nilsa C Ramirez; Bradley J Monk; Joan L Walker; Eric Eisenhauer; Bang H Hoang
Journal:  Int J Gynecol Cancer       Date:  2016-01       Impact factor: 3.437

Review 4.  Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.

Authors:  Tura C Camilli; Ashani T Weeraratna
Journal:  Biochem Pharmacol       Date:  2010-03-06       Impact factor: 5.858

5.  Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomas.

Authors:  Joanna Przybyl; Magdalena Kowalewska; Anna Quattrone; Barbara Dewaele; Vanessa Vanspauwen; Sushama Varma; Sujay Vennam; Aaron M Newman; Michal Swierniak; Elwira Bakuła-Zalewska; Janusz A Siedlecki; Mariusz Bidzinski; Jan Cools; Matt van de Rijn; Maria Debiec-Rychter
Journal:  JCI Insight       Date:  2017-06-02

6.  Enhanced estrogen-induced proliferation in obese rat endometrium.

Authors:  Qian Zhang; Qi Shen; Joseph Celestino; Michael R Milam; Shannon N Westin; Robin A Lacour; Larissa A Meyer; Gregory L Shipley; Peter J A Davies; Lei Deng; Adrienne S McCampbell; Russell R Broaddus; Karen H Lu
Journal:  Am J Obstet Gynecol       Date:  2009-02       Impact factor: 8.661

7.  Molecular profiling of endometrial malignancies.

Authors:  Norasate Samarnthai; Kevin Hall; I-Tien Yeh
Journal:  Obstet Gynecol Int       Date:  2010-03-28

8.  Low expression of secreted frizzled-related protein 2 and nuclear accumulation of β-catenin in aggressive nonfunctioning pituitary adenoma.

Authors:  Youtu Wu; Jiwei Bai; Linchuan Hong; Chunhui Liu; Shengyuan Yu; Guoqiang Yu; Yazhuo Zhang
Journal:  Oncol Lett       Date:  2016-05-13       Impact factor: 2.967

9.  Constitutive activation of Beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice.

Authors:  Pradeep S Tanwar; Ho-Joon Lee; LiHua Zhang; Lawrence R Zukerberg; Makoto M Taketo; Bo R Rueda; Jose M Teixeira
Journal:  Biol Reprod       Date:  2009-04-29       Impact factor: 4.285

10.  Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma.

Authors:  Youtu Wu; Jiwei Bai; Zhenye Li; Fei Wang; Lei Cao; Chunhui Liu; Shengyuan Yu; Guoqiang Yu; Yazhuo Zhang
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.